-
Capricor Therapeutics Announces Positive 4-Year Data from HOPE-2 Open-Label Extension Study of Deramiocel in Duchenne Muscular Dystrophy
20 Jun 2025 13:25 GMT
… muscle leads to cardiomyopathy and heart failure, which is the leading cause … from the FDA. About Capricor Therapeutics Capricor Therapeutics (NASDAQ: CAPR) is a … oligonucleotides, proteins and small molecule therapeutics to potentially treat and prevent …
-
40% of Patients With Heart Failure Don’t See Cardiologist Annually, Increasing Risk of Death
20 Jun 2025 02:23 GMT
… with deaths or hospitalisation in heart failure patients at the national level … with heart failure led to reduced diagnostic testing and guideline-directed medical therapy … 25% in those hospitalized for heart failure within the past year, highlighting …
-
Construction and Validation of a Hospital Mortality Risk Model for Advanced Elderly Patients with Heart Failure Based on Machine Learning
19 Jun 2025 17:34 GMT
… records of elderly patients with heart failure, including: (1) Basic demographic … hospitalized for heart failure in China: results from the China Heart Failure (China-HF … -proBNP-guided therapy on all-cause mortality in chronic heart failure with reduced …
-
Ceryx Medical secures $15 million to advance groundbreaking heart failure technology
19 Jun 2025 14:54 GMT
… developing next-generation bioelectronic therapies for heart failure, has announced the successful … support for patients with chronic heart failure. Unlike conventional pacemakers, Ceryx … innovation that could redefine how heart failure is treated.”
The round …
-
Optimizing Advanced Cancer Therapies and Addressing Logistical, Financial Challenges
20 Jun 2025 02:23 GMT
… (CAR) T-cell therapy and bispecific antibodies for … especially when choosing between therapies like bispecifics or CAR … ; patients with renal failure, heart failure, other issues, and they … trial opportunities for novel therapies. Cleveland Clinic. August 30 …
-
Dark Genome Therapeutics Market Size To Reach USD 11,945.7 Million In 2032
19 Jun 2025 13:40 GMT
… Therapeutics
oHERVolution Therapeutics
oHAYA Therapeutics
oNucleome Therapeutics
oEnhanc3D Genomics Ltd
oNextRNA Therapeutics
oAmaroq Therapeutics … candidate HTX-001 in heart failure, as well as … Vaccines
oDark Genome Therapeutics
.Target Type Outlook …
-
Medications for Heart Failure Market Report 2025 – Strategic Insights for Expansion, Growth & Competitive Edge
18 Jun 2025 11:03 GMT
… , a strong pipeline of combination therapies and fixed-dose formulations, updated … the development and enhancement of therapies to better manage symptoms and … The Medications For Heart Failure Market?
The medications for heart failure market can be …
-
HELP Therapeutics and China Resources Sanjiu partner to co─develop and commercialize HiCM─188 for advanced heart failure
18 Jun 2025 11:11 GMT
… commercialize the investigational cell therapy HiCM-188.
Heart failure remains a major … first iPSC-derived regenerative therapy for heart failure to receive IND clearance … noted that HELP Therapeutics'; focus on heart failure addresses a critical clinical …
-
Novel cardiology therapy for cats is launched
18 Jun 2025 22:21 GMT
A new therapy for managing ventricular hypertrophy … focus remained on the novel therapy.1
“It is indeed … , which can lead to heart failure and other complications, including … disease develop symptoms of congestive heart failure, many others remain subclinical …
-
MedTech developing therapies for heart failure raises extra £5m
17 Jun 2025 00:53 GMT
… , which is developing next-generation therapies for heart failure, raised the funds from … support for patients with chronic heart failure.
THG cuts headcount by 40% … innovation that could redefine how heart failure is treated.”
Spun out of …